Journal metric profile

Anti-Cancer Agents in Medicinal Chemistry

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 3.000 2025 metric year
5-Year Impact Factor 2.800 Longer citation window
JCR Quartile Q2 Subject-category quartile
JCR Category Rank 144/326 Recorded category rank

Anti-Cancer Agents in Medicinal Chemistry JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Anti-Cancer Agents in Medicinal Chemistry metric snapshot

Anti-Cancer Agents in Medicinal Chemistry has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is BENTHAM SCIENCE PUBL LTD. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 3.000. The five-year Journal Impact Factor is 2.800, giving a second citation window for comparison. The journal is recorded in quartile Q2 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 144 out of 326 journals. Based on that rank position, the journal sits within approximately the top 44% of the listed category. Its listed quartile is Q2. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.800) is 0.200 points lower than the standard Journal Impact Factor (3.000). Without journal self-citations, the Impact Factor is 2.900, a difference of 0.100 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.590. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Anti-Cancer Agents in Medicinal Chemistry lists total cites: 6,048; total articles: 120; citable items: 154. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 5.8 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6.5 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Anti-Cancer Agents in Medicinal Chemistry is identified in this directory by print ISSN 1871-5206 and electronic ISSN 1875-5992. The publisher is recorded as BENTHAM SCIENCE PUBL LTD. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameAnti-Cancer Agents in Medicinal Chemistry
Abbreviated journalANTI-CANCER AGENT ME
PublisherBENTHAM SCIENCE PUBL LTD
Metric year2025
Overall rank4,882
ISSN1871-5206
eISSN1875-5992
Total cites6,048
Total articles120
Citable items154
Cited half-life5.8 years
Citing half-life6.5 years
JCR-based Journal Impact Factor3.000
5-Year Impact Factor2.800
Impact Factor without journal self-cites2.900
Journal Citation Indicator0.590
JCR Impact Factor quartileQ2
JCR category rank144/326
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Anti-Cancer Agents in Medicinal Chemistry?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Anti-Cancer Agents in Medicinal Chemistry is 3.000 for the 2025 metric year.

What are the JCR quartile and category rank of Anti-Cancer Agents in Medicinal Chemistry?

Anti-Cancer Agents in Medicinal Chemistry is listed with quartile Q2 and category rank 144/326. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Anti-Cancer Agents in Medicinal Chemistry?

The five-year Journal Impact Factor recorded for Anti-Cancer Agents in Medicinal Chemistry is 2.800. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Anti-Cancer Agents in Medicinal Chemistry?

Anti-Cancer Agents in Medicinal Chemistry is listed in this directory as being published by BENTHAM SCIENCE PUBL LTD.

Additional records from the same publisher or with a similar listed JCR Impact Factor.